Neumora Therapeutics NMRA
NASDAQ NMRA
$0.44 -0.03 (-5.48%)
As of: Oct 21, 2026 · 10:33 AM EDT

Neumora Therapeutics (NMRA) Interest Paid (2025 - 2026)

Updated

Analysis

Neumora Therapeutics (NMRA) Interest Paid (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,128.06 Bn 1,096.64 Bn 19.71 Bn -
2 Johnson & Johnson 615.47 Bn 534.00 Bn 17.26 Bn -
3 AbbVie 504.80 Bn 477.91 Bn 12.70 Bn -
4 Merck 368.45 Bn 322.83 Bn 12.21 Bn -
5 Novartis Ag 298.44 Bn 262.43 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.92 Bn 235.60 Bn 12.86 Bn 1.07 Bn
7 Amgen 236.10 Bn 191.50 Bn 7.24 Bn -
8 Gilead Sciences 190.71 Bn 164.91 Bn 6.22 Bn -
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 1.25 Bn
10 Neumora Therapeutics 81.38 Mn -536.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.46 Mn
Dec 31, 2025 833,000.00
Sep 30, 2025 534,000.00
Jun 30, 2025 134,000.00
API Access

Neumora Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=NMRA&period=max&api_key=YOUR_API_KEY